| 研究生: |
楊佳馨 Chia-Hsin Yang |
|---|---|
| 論文名稱: |
BP023W在頭頸癌中的細胞毒性與調控機制 The Cytotoxic Effects and the Regulatory Mechanism of BP023W on Head and Neck Cancer |
| 指導教授: | 蘇立仁 |
| 口試委員: | |
| 學位類別: |
碩士 Master |
| 系所名稱: |
生醫理工學院 - 系統生物與生物資訊研究所 Graduate Institute of Systems Biology and Bioinformatics |
| 論文出版年: | 2018 |
| 畢業學年度: | 106 |
| 語文別: | 英文 |
| 論文頁數: | 72 |
| 中文關鍵詞: | 頭頸部麟狀上皮細胞癌 、中草藥 、次世代定序 、生物資訊 、細胞凋亡 |
| 外文關鍵詞: | Head and Neck squamous cell carcinoma, Traditional Chinese Medicine, RNA-seq, Bioinformatics, Apoptosis |
| 相關次數: | 點閱:10 下載:0 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
頭頸癌是全世界最常見的六大癌症之一,每年都有超過350,000人因頭頸癌死亡。超過75%的頭頸癌病患都是因為長期的抽菸與酗酒而導致癌症。頭頸癌患者通常都在癌症後期才被診斷,治療後的預後效果也不如預期,化療的藥物也伴隨著嚴重的副作用。中草藥治療已經在中國已經有多年的記載並且指出有較低的毒性與副作用。我們希望透過中草藥找到能夠治療頭頸癌並且不要造成病患有嚴重副作用與降低藥物毒性所造成的影響。我們首先從54種中藥中做篩選,篩選出麻黃 (BP023W) 做為候選藥物。從實驗中我們確實看見了麻黃能夠有效的抑制頭頸癌細胞株的生長。我們利用流式細胞儀檢視出BP023W對於頭頸癌細胞株不是抑制生長而是促使細胞走向死亡,並且利用西方墨點法發現BP023W在高濃度時細胞程序性凋亡蛋白被啟動,證明細胞走向凋亡。最後我們透過次世代定序更全面的探討麻黃在頭頸癌細胞株中的調控,在分析過程中確實也看到的大量與死亡相關的調控機制來證明確實麻黃是造成頭頸癌細胞凋亡。因此,我們認為BP023W可能可以成作為頭頸癌的一個治療的候選藥物。
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, resulting in more than 350,000 deaths every year. More than 75% of cases of HNSCC are attributable to long-term smoking and alcohol consumption. HNSCC patients are often diagnosed at a late stage and the prognosis is poor. Chemotherapy is the mainstream treatment, but often causes serious side effects. Traditional Chinese medicines (TCMs) herbs have been documented for medical use in China for many years. Studies have found that TCMs can reduce the incidence of chemotherapy-induced side effects. In this study, we screened 54 TCMs and found that BP023W, a family of Ephedra. BP023W was found to inhibit the cell viability of Head and neck cancer (HNC) cell lines by Alarmar Blue assay. The term of apoptosis was proved by western blotting and flow cytometry in our study. The RNA sequencing data also showed that BP023 can induce HNC cell lines apoptosis. In the end, we think BP023W might be a candidate for HNC treatment.
1. Cognetti, D. M., Weber, R. S., & Lai, S. Y., Head and Neck Cancer: An Evolving Treatment Paradigm. Cancer, 2008. 130(70): p. 1911-1932.
2. Worsham, M. J., Ali, H., Dragovic, J., & Schweitzer, V. P., Molecular Characterization of Head and Neck Cancer: How Close. MOL DIAGN THER, 2012. 16(4): p. 209-222.
3. Health Promotion Administration, Ministry of Health and Welfare, Taiwan
4. Hsiao, W. W., & Liu, L., The Role of Traditional Chinese Herbal Medicines in Cancer Therapy – from TCM Theory to Mechanistic Insights. Planta Med, 2010. 76(11): p. 1118-1131.
5. Min, L.-W., Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Letters, 2013. 332(2): p. 304-312.
6. Davey, J., Hohenlohe, P., Etter, P., Boone, J., Catchen, J., & Blaxter, M., Genome-wide genetic marker discovery and genotyping using next-generation sequencing. nature reviews genetic, 2011. 12(7): p. 499-510.
7. Edgar , R., Domrachev, M., & Lash, A. E., Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research, 2012. 30(1): p. 207-210.
8. Shiu, L.-Y., Lai, C.-H., Yang, C.-H., Tseng, A. H., Lee, H.-C., & Su, L.-J., Identification of Genomic Alterations in Head and Esophageal Squamous Cell Carcinoma. International Journal of Head and Neck Science, 2017. 1(1): p. 47-84.
9. Yang, C.-H., Lin, R.-D., Lee, M.-H., Tsai, M.-H., & Su, L.-J., Genomic Alterations of Extrectra Cellular Genes as Diagnosis Markers for Head and Neck Squamous Cell Carcinoma. International Journal of Head and Neck Science, 2018. 2(1): p. 21-24.
10. Shi, J., & Walker, M. G., Gene Set Enrichment Analysis (GSEA) for Interpreting Gene Expression Profiles. Current Bioinformatics, 2007. 2(2): p. 133-137.
11. Liu, C., Su, J., Yang, F., Wei, K., Ma, J., & Zhou, X., Compound signature detection on LINCS L1000 big data. Molecular BioSystem, 2015. 11(3): p. 714-722.
12. Kim, H.-J., Park, S.-H., Lee, T.-H., Nahm, B.-H., Kim, Y.-R., & Kim, H.-Y., Microarray detection of food-borne pathogens using specific probes prepared by comparative genomics. Biosensors and Bioelectronics, 2008. 24(2): p. 238-246.
13. Trapnell, C., Roberts, A., Goff, L. A., Pachter, L., Pertea, G., Kim, D., . . . Rinn, J. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protocol, 2012. 7(3): p. 562-78.
14. Elegbede, J., Flores, R., & Wang, R., Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. Life Sciences, 2003. 73(22): p. 2831-2840.
15. Boccaccio, C., & Comoglio, P., A Functional Role for Hemostasis in Early Cancer Development. Cancer Research, 2005. 65(19): p. 8579-8582.
16. Francis, J., Biggerstaff, J., & Amirkhosravi, A., Hemostasis and Malignancy. Semin Thromb Hemost, 1998. 24(2): p. 93-109.
17. Kageshita, T., Kashio, Y., Yamauchi, A., Seki, M., Abedin, M. J., Nishi, N., . . . Hirashima, M., Possible role of galectin‐9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. International Journal of Cancer, 2002. 99(6): p. 809-816.
18. Yang, R.-Y., & Liu, F.-T., Galectins in cell growth and apoptosis. Cellular and Molecular Life Sciences, 2003. 60(2): p. 267-276.
19. Winslow, L., & Kroll, D., Herbs as Medicines. Arch Intern Med., 1998. 158(20): p. 2192-2199.